文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

精神分裂症患者与普通人群之间17年的预期寿命差距背后的原因是什么?

What is behind the 17-year life expectancy gap between individuals with schizophrenia and the general population?

作者信息

Popa Andreea-Violeta, Ifteni Petru Iulian, Țâbian Daniel, Petric Paula Simina, Teodorescu Andreea

机构信息

Faculty of Medicine, Transilvania University of Brasov, Brasov, Romania.

Clinical Hospital of Psychiatry and Neurology of Brașov, Brasov, Romania.

出版信息

Schizophrenia (Heidelb). 2025 Aug 29;11(1):117. doi: 10.1038/s41537-025-00667-1.


DOI:10.1038/s41537-025-00667-1
PMID:40883322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12397424/
Abstract

Individuals with schizophrenia face significantly higher mortality rates than the general population, with a typical reduction in life expectancy of 15-20 years. This study investigated 10-year all-cause mortality and its clinical correlates in a Romanian cohort of patients with schizophrenia, using real-world clinical and hospital and forensic records. A total of 635 individuals hospitalized between 2010 and 2013 were followed for 10 years. Mortality rates, causes of death, and risk factors were assessed using Cox regression models and standardized mortality ratios (SMRs). During the follow-up, 123 patients (19.37%) died, corresponding to a mortality rate of 21.3 per 1000 person-years. The SMR was 1.58 compared to the Romanian general population. Non-violent causes predominated, with cardiovascular disease (27.64%) and infections (17.07%) being the most frequent. Violent deaths, including suicides and accidents, accounted for 17.07% of all mortality. The mean age at death was 58.97 years, reflecting a 17-year reduction in life expectancy. Age was the strongest independent predictor of mortality (HR = 1.07, p < 0.001). Use of second-generation antipsychotics (HR = 0.37, p < 0.001) and low frequency hospitalization (HR = 0.09, p < 0.001) were significantly associated with reduced all-cause and cause-specific mortality. Schizophrenia is associated with significantly increased premature mortality, primarily due to preventable physical illnesses and violent deaths. Early intervention, sustained treatment adherence, and integrated medical care are essential to improve survival outcomes.

摘要

精神分裂症患者的死亡率显著高于普通人群,预期寿命通常会缩短15至20年。本研究利用真实世界的临床、医院和法医记录,调查了罗马尼亚一组精神分裂症患者的10年全因死亡率及其临床相关因素。对2010年至2013年间住院的635名个体进行了为期10年的随访。使用Cox回归模型和标准化死亡率(SMR)评估死亡率、死亡原因和风险因素。在随访期间,123名患者(19.37%)死亡,死亡率为每1000人年21.3例。与罗马尼亚普通人群相比,SMR为1.58。非暴力原因占主导,心血管疾病(27.64%)和感染(17.07%)最为常见。包括自杀和事故在内的暴力死亡占所有死亡人数的17.07%。平均死亡年龄为58.97岁,反映出预期寿命缩短了17年。年龄是死亡率最强的独立预测因素(HR = 1.07,p < 0.001)。使用第二代抗精神病药物(HR = 0.37,p < 0.001)和低频率住院(HR = 0.09,p < 0.001)与全因死亡率和特定原因死亡率的降低显著相关。精神分裂症与过早死亡率显著增加有关,主要是由于可预防的身体疾病和暴力死亡。早期干预、持续的治疗依从性和综合医疗护理对于改善生存结果至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7079/12397424/f99492ee8a35/41537_2025_667_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7079/12397424/92bcf8d4ac13/41537_2025_667_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7079/12397424/217e51d45357/41537_2025_667_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7079/12397424/f99492ee8a35/41537_2025_667_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7079/12397424/92bcf8d4ac13/41537_2025_667_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7079/12397424/217e51d45357/41537_2025_667_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7079/12397424/f99492ee8a35/41537_2025_667_Fig3_HTML.jpg

相似文献

[1]
What is behind the 17-year life expectancy gap between individuals with schizophrenia and the general population?

Schizophrenia (Heidelb). 2025-8-29

[2]
Prescription of Controlled Substances: Benefits and Risks

2025-1

[3]
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.

MMWR Surveill Summ. 2025-6-12

[4]
All-Cause Mortality and Specific Causes of Death in Autism: A Nationwide Analysis.

Autism Adulthood. 2025-2-5

[5]
Surveillance for Violent Deaths - National Violent Death Reporting System, 48 States, the District of Columbia, and Puerto Rico, 2020.

MMWR Surveill Summ. 2023-5-26

[6]
Lipid-lowering drug treatment and mortality among individuals ≥75 years without cardiovascular disease: a population-based cohort study.

Eur J Prev Cardiol. 2025-8-29

[7]
Cannabis and schizophrenia.

Cochrane Database Syst Rev. 2014-10-14

[8]
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Health Technol Assess. 2006-8

[9]
Endovascular repair of abdominal aortic aneurysm.

Cochrane Database Syst Rev. 2014-1-23

[10]
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases.

Cochrane Database Syst Rev. 2025-5-6

本文引用的文献

[1]
Pre- and Post- COVID-19 Pandemic Pneumonia Rates in Hospitalized Schizophrenia Patients.

Medicina (Kaunas). 2025-7-10

[2]
Life expectancy associated with specific mental disorders and the contribution of causes of death: a population-based study in the region of Catalonia.

Psychiatry Res. 2025-6

[3]
Severe mental illness and infectious disease mortality: a systematic review and meta-analysis.

EClinicalMedicine. 2024-10-9

[4]
Risk Factors for Natural Cause Mortality in Schizophrenia.

JAMA Netw Open. 2024-9-3

[5]
All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis.

Mol Psychiatry. 2025-1

[6]
Investigating in VigiBase over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: focus on high lethality and the association with aspiration pneumonia.

Expert Opin Drug Metab Toxicol. 2024-8

[7]
Life expectancy and years of potential life lost in people with mental disorders: a systematic review and meta-analysis.

EClinicalMedicine. 2023-10-31

[8]
Predictors of Mortality Following a Schizophrenia Spectrum Diagnosis: Evidence From the 20-Year Follow-up of the OPUS Randomized Controlled Trial.

Schizophr Bull. 2023-9-7

[9]
The revolving door phenomenon in severe psychiatric disorders: A systematic review.

Int J Soc Psychiatry. 2023-8

[10]
Risk factors for lower respiratory tract infections in a psychiatric hospital: a retrospective study.

J Infect Dev Ctries. 2023-4-30

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索